France near infrared imaging market is anticipated to grow at a CAGR around 9.1% during the forecast period. According to world cancer research fund international, France has the 3rd highest rate of the breast cancer among European Union. There has been improvement in the technology in breast cancer detection technology including improvements in current techniques and new detection strategies aimed at finding distinctive molecular signatures of a pre-malignant or malignant breast tumor. Some of the major technological advancement in breast cancer are digital mammography, computer-aided detection, ultrasound imaging, near-infrared imaging. Several other imaging systems are developed especially for the detection of breast cancer. France is the largest economy in the EU. Most of the chronic diseases are 100% covered by French statuary health insurance. Healthcare system in France is one of the universal health care majorly financed by government national health insurance. Universal medical coverage was introduced in 2000.
To Request a Sample of our Report on France Near Infrared Imaging Market: https://www.omrglobal.com/request-sample/france-near-infrared-imaging-market
France near infrared imaging market is segmented on the basis of disease and technology. Based on disease, the market is segmented into cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries and plastic surgeries. Based on technology, the market is segmented into fluorescence imaging and bioluminescence imaging.
(Get 15% Discount on Buying this Report)
A full Report of France Near Infrared Imaging Market is Available at: https://www.omrglobal.com/request-sample/france-near-infrared-imaging-market
France Near Infrared Imaging Market Segmentation
By Disease
· Cancer Surgeries
· Gastrointestinal Surgeries
· Cardiovascular Surgeries
· Plastic Surgeries
By Technology
· Fluorescence Imaging
· Fluorescence Reflectance Imaging (FRI)
· Tomographic Fluorescence Imaging
· Bioluminescence Imaging
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
